Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Lacosamide in Neonatal Status Epilepticus: A Randomized Controlled Study

NCT05291455 is registered in ClinicalTrials.gov with Sherief Abd-Elsalam as lead sponsor.

NCT NCT05291455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05291455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Lacosamide in Neonatal Status Epilepticus: A Randomized Controlled Study
Lead sponsor
Sherief Abd-Elsalam
Phase
Phase 3
Overall status
Unknown status
Start date
March 1, 2022
Completion date
April 1, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy